MedPath
FDA Approval

Fosrenol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lanthanum carbonate(1000 mg in 1 1)

Manufacturing Establishments8

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Patheon Manufacturing Services LLC

Takeda Pharmaceuticals America, Inc.

079415560

Element Materials Technology Pharma US LLC

Takeda Pharmaceuticals America, Inc.

081315325

Microbac Laboratories, Inc.

Takeda Pharmaceuticals America, Inc.

178463126

Triclinic Labs

Takeda Pharmaceuticals America, Inc.

017662237

Catalent Germany Schorndorf GmbH

Takeda Pharmaceuticals America, Inc.

315732628

BCM Ltd

Takeda Pharmaceuticals America, Inc.

230780322

Reckitt Benckiser Healthcare International Ltd.

Takeda Pharmaceuticals America, Inc.

230780363

Reading Scientific Services Ltd (RSSL)

Takeda Pharmaceuticals America, Inc.

293610085

Products5

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fosrenol

Product Details

NDC Product Code
54092-254
Application Number
NDA021468
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 20, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 490D9F069TClass: ACTIMQuantity: 1000 mg in 1 1
DEXTRATESInactive
Code: G263MI44RUClass: IACT

Fosrenol

Product Details

NDC Product Code
54092-253
Application Number
NDA021468
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 20, 2023
Code: 490D9F069TClass: ACTIMQuantity: 750 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
DEXTRATESInactive
Code: G263MI44RUClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Fosrenol

Product Details

NDC Product Code
54092-252
Application Number
NDA021468
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 20, 2023
Code: 490D9F069TClass: ACTIMQuantity: 500 mg in 1 1
DEXTRATESInactive
Code: G263MI44RUClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Fosrenol

Product Details

NDC Product Code
54092-257
Application Number
NDA204734
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 20, 2023
DEXTRATESInactive
Code: G263MI44RUClass: IACT
Code: 490D9F069TClass: ACTIMQuantity: 1000 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Fosrenol

Product Details

NDC Product Code
54092-256
Application Number
NDA204734
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 20, 2023
Code: 490D9F069TClass: ACTIMQuantity: 750 mg in 1 1
DEXTRATESInactive
Code: G263MI44RUClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath